Transfuse OTL-103 in Central Vein, Perc, New Tech 8

This code describes the administration of OTL-103, a novel therapeutic agent, directly into a central vein. The procedure is performed percutaneously, meaning through the skin, without an open surgical incision. This represents a new technology intervention for specific medical conditions.

This code is used when a patient receives OTL-103 via a central venous catheter inserted through the skin. This typically applies to investigational or newly approved therapies where OTL-103 is indicated for conditions such as rare genetic disorders or specific oncological treatments requiring systemic delivery.

• Ensure documentation clearly specifies "OTL-103" as the substance transfused, not a generic blood product or other therapeutic agent.
• Verify the approach is explicitly documented as "percutaneous" and the site is a "central vein" (e.g., subclavian, jugular, femoral).
• Confirm that this procedure is performed in an inpatient setting, as ICD-10-PCS codes are for inpatient procedures only.